Pharmafile Logo
Pharmafocus logo
Advanced Search
artificial-intelligence-2228610_640

New AI system for lung cancer and heart disease could save NHS billions

January 4, 2018
Research and Development, Sales and Marketing Optellum, Oxford, Sir John Bell, heart disease, lung cancer, pharma

A team of researchers at Oxford’s John Radcliffe Hospital have unveiled a new artificial intelligence system which they claim could …

News
allergan-westport-ireland_web

Allergan to axe over 1,000 positions in cost cutting measures

January 4, 2018
Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

Allergan was never far away from the headlines in 2017, particularly when it came to its second highest selling product, …

News
kress

Syntimmune brings in new CEO from Biogen

January 4, 2018
Syntimmune, biotech, drugs, pharma, pharmaceutical

Syntimmune has revealed that it has brought in a new CEO to begin the new year, with the appointment of …

Appointment
eye-1173863_960_720

Spark’s bright idea on $850,000 blindness gene therapy

January 3, 2018
Sales and Marketing : Pharma, Spark Therapeutics, biotech, drugs, pharma, pharmaceutical

Spark Therapeutics knew that it had to think very carefully about where it pitched its price for its inarguably ground-breaking …

News

J&J’s predicted blockbuster depression posts P2 data

January 3, 2018
Research and Development Johnson & Johnson, biotech, depression, drugs, pharma, pharmaceutical

Johnson & Johnson has revealed Phase 2 data for its treatment for depression, esketamine, and the results are positive. The …

News
Novartis image

Novartis’ Kisqali gains breakthrough status in premenopausal breast cancer

January 3, 2018
Research and Development, Sales and Marketing Kisqali, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis has received a major boost in its efforts to broaden use of its CDK4/6 inhibitor, by receiving a breakthrough …

News
mallinckrodt

Mallinckrodt bolsters business with $1.2bn buyout

January 3, 2018
Research and Development, Sales and Marketing Mallinckrodt, drugs, pharma, pharmaceutical, sucampo

Mallinckrodt has endured a tough 2017, with its share price falling by half over the course of the year. This …

News

Winter crisis hits, NHS hospitals cancel non-emergency operations

January 3, 2018
Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical

There was ample warning that the NHS looked set to face another difficult winter season, the predictions now look to …

News
age

Diabetes drugs show potential in treating Alzheimer’s

January 3, 2018
Research and Development Alzheimer's disease, biotech, drugs, pharma, pharmaceutical

A group of researchers at Lancaster University have identified a drug currently used to treat type 2 diabetes that has …

News
epidiolex-100mg-carton-bottle-unenhanced-0074c-j10

GW Pharma applies to both EU and US for lead product

January 2, 2018
Manufacturing and Production, Sales and Marketing GW Pharma, biotech, drugs, pharma, pharmaceutical

GW Pharmaceuticals had a busy festive period, after it announced that it had submitted to both the EU and the …

News
Pfizer headquarters

NICE to take another look at Pfizer’s leukaemia drug

January 2, 2018
Manufacturing and Production, Sales and Marketing NICE, Pfizer, biotech, drugs, pharma, pharmaceutical

Back in August of 2017, NICE rejected Pfizer’s Besponsa on cost-effectiveness grounds and the pharma giant was not best pleased. …

News
dermapace-product

FDA approves shock wave wound healing device

January 2, 2018
Manufacturing and Production, Sales and Marketing FDA, biotech, drugs, pharma, pharmaceutical

Continuing its recent trend to promote innovative new technologies, the FDA has announced that it has approved a medical device …

News
mylan_building

Mylan and Biocon biosimilar approval expands to Brazil

January 2, 2018
Manufacturing and Production, Sales and Marketing Biocon, Herceptin, Mylan, biosimilar, biotech, drugs, pharma, pharmaceutical

Since Mylan and Biocon managed to gain US FDA approval for its Herceptin (Trastuzumab) biosimilar, it has forged ahead in …

News
valeant

Valeant and Pershing take $290m hit over insider trading

January 2, 2018
Manufacturing and Production, Sales and Marketing Bill Ackman, Pershing Square, Valeant, biotech, drugs, pharma, pharmaceutical

Valeant Pharmaceuticals will be hoping it can begin 2018 as a fresh start, after a turbulent few years, to say …

News
4420456374_64a3d7e6aa

Pharmafile.com’s top ten stories of 2017

December 22, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Actelion, Amgen, AstraZeneca, Cyber attack, EMA, European Commission, Humira, J&J, JJ, Johnson & Johnson, MSD, Sanofi, Shire, Teva, biosimilar, brexit

After a packed year that has flown by, we’ve reached the final top ten of 2017. Below you can find …

News
2018

Seven pharma trends for 2018

December 22, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2018, M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing

Pharmafile.com looks ahead to signpost what we expect will be the key industry trends through the course of 2018.The value of …

Feature
fda2outsideweb

La Jolla Pharmaceutical scores FDA approval for blood pressure treatment

December 22, 2017
Medical Communications, Sales and Marketing FDA, La Jolla pharmaceutical, blood pressure, pharma

The FDA has announced that it has approved La Jolla Pharmaceutical’s Giapreza (angiotensin II) injection for intravenous infusion to increase …

News

Novartis hit by court loss, could spur numerous cases across industry

December 22, 2017
Medical Communications, Sales and Marketing Novartis, biotech, drugs, pharma, pharmaceutical

In a landmark ruling, a Californian court has found that a brand name manufacturer of a drug could be held …

News

Roche boosts oncology portfolio with $1.7bn acquisition

December 22, 2017
Medical Communications, Sales and Marketing Roche, biotech, drugs, ignyta, pharma, pharmaceutical

Roche has announced that it will buy Ignyta, a San Diego-based biotech that has a pipeline of oncology drugs, for …

News
nerve-cell-2213009_960_720

Eisai and Biogen Alzheimer’s drug stumbles at P2

December 21, 2017
Medical Communications, Research and Development Biogen, Eisai, biotech, drugs, pharma, pharmaceutical

Only a few months ago, it was announced that Eisai had decided to opt into the development process of BAN2401. …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026